MicroRNA Analysis in Normal Human Oral Keratinocytes and YD-38 Human Oral Cancer Cells.
- Author:
Hye Ryun KIM
1
;
Euteum PARK
;
Kwang Hee CHO
;
Do Kyung KIM
Author Information
1. Oral Biology Research Institute, School of Dentistry, Chosun University, Gwangju, Korea. kdk@chosun.ac.kr
- Publication Type:Original Article
- Keywords:
cell growth inhibition;
miRNA;
NHOK;
oncogenes;
oral cancer cells;
tumor suppressors
- MeSH:
Apoptosis;
Cell Proliferation;
Gene Expression;
Humans;
Keratinocytes;
MicroRNAs;
Mouth Neoplasms;
Neoplasm Metastasis;
Nucleotides;
Oncogenes;
RNA, Messenger;
RNA, Small Untranslated
- From:International Journal of Oral Biology
2011;36(4):179-185
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
MicroRNAs (miRNAs) are small non-coding RNAs that mediate gene expression at the post-transcriptional level by degrading or repressing targeted mRNAs. These molecules are about 21-25 nucleotides in length and exert their effects by binding to partially complementary sites in mRNAs, predominantly in the 3'-untranslated region (3'-UTR). Recent evidence has demonstrated that miRNAs can function as oncogenes or tumor suppressors through the modulation of multiple oncogenic cellular processes in cancer development, including initiation, cell proliferation, apoptosis, invasion and metastasis. In our present study, we examined the expression profile of miRNAs related to oral cancer cell growth inhibition using normal human oral keratinocytes (NHOK) and YD-38 human oral cancer cells. By miRNA microassay analysis, 40 and 31 miRNAs among the 1,769 examined were found to be up- and down-regulated in YD-38 cells compared with NHOK cells, respectively. Using qRT-PCR analysis, the expression levels of miR-30a and miR-1246 were found to be increased in YD-38 cells compared with NHOK cells, whereas miR-203 and miR-125a were observed to be decreased. Importantly, the overexpression of miR-203 and miR-125a significantly inhibited the growth of YD-38 cells. This finding and the microarray data indicate the involvement of specific miRNAs in the development and progression of oral cancer.
